Date: 2015-01-20
Type of information: Loan
Company: Gecko Biomedical (France)
Investors: BpiFrance (France)
Amount: € 1.3 million
Funding type: loan
Planned used: Gecko Biomedical is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. Gecko Biomedical is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham and Women’s Hospital). The funds will be used to advancing the manufacturing scale-up of Gecko Biomedical’s Liquid Film platform, and the completion of the non-clinical development plan for regulatory purposes.
Others: * On January 20, 2015, Gecko Biomedical announced the company has received € 1.3 million from Bpifrance to advance its bio-inspired Surgical Adhesive Solutions. The funds are part of Bpifrance’s supports to innovation through its Aide au Développement de l’Innovation (ADI) program, providing repayable advances to encourage the development of innovative products. Gecko Biomedical was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Management.
Therapeutic area: Medical devices
